Chesley Taft & Associates LLC Astrazeneca PLC Transaction History
Chesley Taft & Associates LLC
- $2.05 Billion
- Q1 2025
A detailed history of Chesley Taft & Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 131,910 shares of AZN stock, worth $9.29 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
131,910
Previous 3,400
3779.71%
Holding current value
$9.29 Million
Previous $222,000
4267.12%
% of portfolio
0.47%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.86 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.2 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...